title: Recent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?
authors: Diego
authors: D
authors: Conde
authors: Juan Pablo
authors: JP
authors: Costabel
authors: Alberto
authors: A
authors: Alves de Lima
mesh_terms: D000638:Amiodarone / Q000008:administration & dosage / Q000627:therapeutic use*; D000840:Anisoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D003657:Decision Making; D006339:Heart Rate; D006801:Humans; D007262:Infusions, Intravenous; D011759:Pyrrolidines / Q000008:administration & dosage / Q000627:therapeutic use*; D018487:Ventricular Dysfunction, Left / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000840:Anisoles; D000889:Anti-Arrhythmia Agents; D011759:Pyrrolidines; C524581:vernakalant; D000638:Amiodarone